Director and CEO, Alkermes plc of Alkermes Plc (30-Year Financial, Insider Trades) Richard F Pops (insider trades) sold 75,000 shares of ALKS on 05/14/2020 at an average price of $15 a share. The total sale was $1.1 million.
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients. Alkermes PLC has a market cap of $2.36 billion; its shares were traded at around $14.89 with and P/S ratio of 1.99.
CEO Recent Trades:
- Director and CEO, Alkermes plc Richard F Pops sold 75,000 shares of ALKS stock on 05/14/2020 at the average price of $15. The price of the stock has decreased by 0.73% since.
- Director and CEO, Alkermes plc Richard F Pops sold 50,000 shares of ALKS stock on 05/07/2020 at the average price of $14.63. The price of the stock has increased by 1.78% since.
Directors and Officers Recent Trades:
- SVP Finance & CAO, Alks Inc. Iain Michael Brown sold 6,250 shares of ALKS stock on 05/13/2020 at the average price of $15.39. The price of the stock has decreased by 3.25% since.
- SVP, Corp Dev., Alkermes, Inc. Michael J Landine sold 18,000 shares of ALKS stock on 05/12/2020 at the average price of $15.75. The price of the stock has decreased by 5.46% since.
- SVP, Corp Dev., Alkermes, Inc. Michael J Landine sold 25,000 shares of ALKS stock on 05/05/2020 at the average price of $14.06. The price of the stock has increased by 5.9% since.
For the complete insider trading history of ALKS, click here
.
